Sonnet biotherapeutics announces presentations at the 2023 cytokine-based drug development summit and provides preliminary update on the son-080 study in chemotherapy-induced peripheral neuropathy
Princeton, nj / accesswire / june 23, 2023 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that john cini, phd, chief scientific officer and co-founder, and richard kenney, md, chief medical officer, will be featured speakers at the 4th annual cytokine-based drug development summit in boston, massachusetts, june 27-29. presentation details: june 27, 1:00 - 4:00 pmjohn cini will co-lead a workshop entitled, "examining cytokine biology to develop a specific &effective drug" june 29, 2:40 - 3:10 pmrichard kenney will deliver a talk entitled, "a tale of two forms of il-12: the benefits of extending pk" cipn study (sb211) preliminary update in the sb211 study, patients are being randomized to one of three treatment groups that receive 20 Μg son-080, 60 Μg son-080, or a matching placebo in a blinded fashion, three times a week for 12 weeks.
SONN Ratings Summary
SONN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission